83
60
Growth Score 83 in past quarter
-5 pts
Heat Score 60 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
506493
Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases.
- Youxin Wang: Co-Founder
- Qiang Ding: Co-Founder, Deputy GM and Director of Biopharmacology
About the Company
Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases. Leadopharma has established a complete pharmaceutical chemistry and ion channel drug research and development platform and team, which can independently carry out drug synthesis, activity screening, and early safety
pharmacology research for ion channel targets.